InvestorsHub Logo
Followers 40
Posts 3885
Boards Moderated 0
Alias Born 09/30/2010

Re: None

Tuesday, 04/27/2021 8:05:58 AM

Tuesday, April 27, 2021 8:05:58 AM

Post# of 3728
Gilead To Scale Up Remdesivir Availablity In India
April 27 2021 - 03:17AM
TipRanks
Biopharmaceutical company Gilead Sciences is expanding the availability of its COVID-19 treatment Remdesivir in India amid the country’s spike in cases. Gilead (GILD) is providing technical assistance and support for setting up new local manufacturing plants. The company is also donating the active pharmaceutical ingredient (API) to local facilities to help increase the production of the drug in India. Additionally, the company is donating at least 450,000 vials of Veklury to help Indian patients. Remdesivir is marketed in the US under the brand name Veklury.
https://www.tipranks.com/news/gilead-to-scale-up-remdesivir-availablity-in-india
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent LGND News